Viatris Inc Stock Ownership - Who owns Viatris?

Insider buying vs selling

Have Viatris Inc insiders been buying or selling?
Xiangyang Sean NiPresident Greater China2023-03-063,148$11.08
Robert J. CouryExecutive Chairman2023-03-0464,557$11.13
Andrew CuneoPresident JANZ Japan Australia and New Zealand2023-03-04101$11.13
Andrew CuneoPresident JANZ Japan Australia and New Zealand2023-03-042,791$11.13
Rajiv MalikPresident2023-03-041,288$11.13
Rajiv MalikPresident2023-03-0435,808$11.13
Der Meer Mohr Pauline VanDirector2023-03-04589$11.13
Der Meer Mohr Pauline VanDirector2023-03-0422$11.13
Paul CampbellChief Accounting Officer and Corporate Controller2023-03-04282$11.13
Paul CampbellChief Accounting Officer and Corporate Controller2023-03-047,825$11.13

1 of 6

VTRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTRS insiders and whales buy or sell their stock.

VTRS Shareholders

What type of owners hold Viatris Inc stock?
Vanguard Group Inc12.17%145,867,609$1.36BInstitution
Laboratories Abbott11.32%135,750,000$1.27BInsider
Blackrock Inc7.49%89,831,188$838.12MInstitution
Products Abbott5.24%62,782,018$585.76MInsider
State Street Corp4.99%59,777,858$557.73MInstitution
Davis Selected Advisers4.59%55,009,008$513.23MInstitution
Price T Rowe Associates Inc3.44%41,290,966$385.24MInstitution
Geode Capital Management LLC2.20%26,413,851$246.44MInstitution
Camber Capital Management LP1.88%22,500,000$209.93MInstitution
Invesco Ltd1.84%22,002,472$205.28MInstitution

1 of 3

VTRS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTRS75.14%17.68%Net SellingNet Selling
TEVA49.69%0.79%Net SellingNet Selling
CTLT78.69%21.31%Net SellingNet Selling
ELAN90.55%9.45%Net SellingNet Buying

Viatris Stock Ownership FAQ

Who owns Viatris?

Viatris (NASDAQ: VTRS) is owned by 75.14% institutional shareholders, 17.68% Viatris insiders, and 7.18% retail investors. Laboratories Abbott is the largest individual Viatris shareholder, owning 135.75M shares representing 11.32% of the company. Laboratories Abbott's Viatris shares are currently valued at $1.27B.

If you're new to stock investing, here's how to buy Viatris stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.